Position
Chief Financial Officer
Company
Cyllene Therapeutics
Description
Cyllene Therapeutics has announced the appointment of Dr. Marc Grasso as Executive Vice-President and Chief Financial Officer. Dr
Quick answer
Cyllene Therapeutics Appoints Marc Grasso as Chief Financial Officer (September 17, 2026). Cyllene Therapeutics is based in Paris, Ile-de-France, France.
- Who is the new Chief Financial Officer at Cyllene Therapeutics?
- Cyllene Therapeutics named Marc Grasso Chief Financial Officer, announced September 17, 2026.
- What did Cyllene Therapeutics announce on September 17, 2026?
- Cyllene Therapeutics has announced the appointment of Dr. Marc Grasso as Executive Vice-President and Chief Financial Officer.
- What does Cyllene Therapeutics do?
- Cyllene Therapeutics, formerly known as EG 427, is a clinical-stage biotechnology company focused on the development of precision genetic medicines for neurological diseases.
- Where is Cyllene Therapeutics based?
- Cyllene Therapeutics is based in Paris, Ile-de-France, France.
- Which similar companies made leadership changes around the same time?
- Paradigm Biopharmaceuticals (September 17, 2026), Oxford Brain Diagnostics (September 15, 2026), AdvanCell (September 15, 2026) and Serapha Bio (September 15, 2026) also announced leadership changes within 45 days of Cyllene Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Paradigm Biopharmaceuticals Appoints Dr Daniel Furtner as Chief Medical Officer (September 17, 2026)
- Oxford Brain Diagnostics Appoints Jieun Choe as Chief Executive Officer (September 15, 2026)
- AdvanCell Appoints Sean Cassidy as Chief Financial Officer (September 15, 2026)
- Serapha Bio Appoints Kenneth T. Mills as Chief Executive Officer and Daphne Karydas as Chief Financial Officer (September 15, 2026)
- Vyome Appoints Jerry Leonard as Chief Financial Officer (September 14, 2026)
- Q32 Bio Appoints José Trevejo as Chief Medical Officer and Ellie Hershberger as Chief Development Officer (September 14, 2026)
Who to call at Cyllene Therapeutics, and when
A new leader at Cyllene Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Cyllene Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Cyllene Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Cyllene Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Cyllene Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Cyllene Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.